Ocean Biomedical Corp (OCEA) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Ocean Biomedical, Inc. (OCEA) litsenziyalash shartnomalari va royalti to'lovlari orqali onkologiya, bezgak va o'pka patologiyalarining ilg'or davolash usullarini tijoratlashtirishga e'tibor qaratadi. Kompaniya parallel loyihalar doirasida yetakchi universitetlarning ishlanmalarini joriy etish orqali risklarni minimallashtiradi. GURU.Markets platformasidagi ushbu bozor qiymati grafigi 0.00 ko'rsatkichini qayd etdi. Hozirgi vaqtda biznes barqaror pul oqimlariga ega emas va investitsiya kapitalining bosqichma-bosqich ishlatilishi orqali faoliyat yuritmoqda.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_OCEA_-_Ocean-Biomedical-Inc._-_Long-Term-Debt-to-Capital "OCEA: Ocean Biomedical Uzoq muddatli qarzning kapitalga nisbati 28.04.2023 - 24.05.2025 | 👁️GURU.Markets👁️")
Ocean Biomedical, Inc. (OCEA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Ocean Biomedical, Inc.|OCEA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati oceanbiomedical.com|OCEA - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Ocean Biomedical, Inc.|OCEA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Ocean Biomedical|Tezkor likvidlik ko‘rsatkichi oceanbiomedical.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Ocean Biomedical Inc - OCEA
Ocean Biomedical Amerika Qo'shma Shtatlarida tibbiyotga berilgan gumanitar himoya tufayli barqaror huquqiy maqomga ega. Uzoq muddatli qarzning sof aktivlarga nisbati ko'rsatkichini tahlil qilish orqali investorlar bir yildan ortiq muddatga ega majburiyatlarning kapitalga nisbatdagi ulushini baholaydilar. Ushbu metrika moliyaviy leveraj va kompaniyaning to'lov qobiliyati o'rtasidagi muvozanatni belgilaydi. Pastroq ko'rsatkich xatarlarni minimallashtirsa-da, qarz olishdan butunlay voz kechish o'sishni sekinlashtirishi mumkin. Bozor mo'tadil qarz yukini barqaror rivojlanishning kafolati sifatida baholaydi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SEPN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Pieris Corp|SVRA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati rigel.com|ANAB (AnaptysBio) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Astria Therapeutics Inc ATXS|Uzoq muddatli qarzning kapitalga nisbati ENGN|Uzoq muddatli qarzning kapitalga nisbati rapt.com (RAPT)|Uzoq muddatli qarzning o'z kapitaliga nisbati Aerovate Therapeutics JBIO|ACRS: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|KYTX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TLSA (Tiziana Life Sciences Ltd.)|CABA: Uzoq muddatli qarzning kapitalga nisbati|VTYX (Ventyx Biosciences, Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THTX (Theratechnologies Inc.) - Uzoq muddatli qarzning kapitalga nisbati|avalotx.com (AVTX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Eledon Pharmaceuticals, Inc. (ELDN)|AGEN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Climb Bio, Inc. CLYM|ZURA - Uzoq muddatli qarzning o'z kapitaliga nisbati|aTyr Pharma, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Adagene|IMA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi STTK|EQ (Equillium Inc) - Uzoq muddatli qarzning kapitalga nisbati|Connect Pharma (CNTB) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati IMUX|Uzoq muddatli qarzning o'z kapitaliga nisbati atarabio.com ATRA|Uzoq muddatli qarzning kapitalga nisbati IFRX (InflaRx)|Uzoq muddatli qarzning kapitalga nisbati X4 Pharmaceuticals Inc. XFOR|ACET - Uzoq muddatli qarzning o'z kapitaliga nisbati|CELU: Uzoq muddatli qarzning o'z kapitaliga nisbati|INMB (INmune Bio, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|barinthusbio.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|KZR (Kezar Life Sciences, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|SAB Biotherapeutics Inc. (SABS) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Akari Therapeutics plc (AKTX)|enlivex.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati QTTB (Q32 Bio)|GOVX - Uzoq muddatli qarzning o'z kapitaliga nisbati|EDSA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati iBio Inc IBIO|carismatx.com (CARM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati XTL Bio (XTLB)|BOLT (Bolt Biotherapeutics Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics Inc (HCWB)|Uzoq muddatli qarzning kapitalga nisbati APVO|AIM - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ADTX (Aditxt, Inc.)|Uzoq muddatli qarzning kapitalga nisbati GRI Bio Corporation GRI|XRTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati HIND|REVB: Uzoq muddatli qarzning kapitalga nisbati|Indaptus Therapeutics Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SCNI (Scinai) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati CalciMedica Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati Affimed (AFMD)|ALLK (allakos.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati HOOKIPA Pharma HOOK|IGMS - Uzoq muddatli qarzning o'z kapitaliga nisbati|iTeos - Uzoq muddatli qarzning kapitalga nisbati|TCBP - Uzoq muddatli qarzning kapitalga nisbati|THRD (Third Harmonic Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati